Preoperative metronidazole treatment to evaluate its efficacy in reducing Fusobacterium nucleatum colonisation in colorectal cancer patients: a proof-of-concept trial
Background: Colorectal cancer (CRC) is one of the most prevalent tumour types and a leading cause of cancer-related mortality worldwide. Surgery represents the primary therapeutic option, while advanced cases are typically managed with established chemotherapy protocols, which exhibit variable respo...
Saved in:
| Main Authors: | S. De Dosso, D. Christoforidis, E. Merlo, A. Vannelli, S. Popeskou, P. Gaffuri, G. Lollo, L. Ambrosiani, F. Radaelli, M. Frattini, M. Marengo, K. Galetti, G. Iezzi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | ESMO Gastrointestinal Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S294981982500038X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study
by: Mmadili N. Ilozumba, et al.
Published: (2024-11-01) -
Association of Fusobacterium nucleatum with colorectal cancer molecular subtypes and its outcome: a systematic review
by: Luana Greco, et al.
Published: (2025-01-01) -
Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies
by: Madeline Krieger, et al.
Published: (2024-12-01) -
Association of Fusobacterium nucleatum infection with colorectal cancer in Kazakhstani patients
by: Gulmira Kulmambetova, et al.
Published: (2024-12-01) -
Abscesses of the spine and iliac fossa caused by infection with the opportunistic bacterium Fusobacterium nucleatum
by: YunTao Gu, et al.
Published: (2025-01-01)